Evaluating "superiority", "equivalence" and "non-inferiority" in clinical trials

Annals of Saudi Medicine

Volumn 27, Issue 4, 2007, Pages 284-288

  Turan, Fatma Nesrin ^a   Şenocak, Mustafa ^b  

^a TRAKYA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

BIOAVAILABILITY; BIOEQUIVALENCE; CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA ANALYSIS; DRUG COST; HUMAN; METHODOLOGY; NULL HYPOTHESIS; PRIORITY JOURNAL; QUANTITATIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; UNSPECIFIED SIDE EFFECT;

EID: 34948876462     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.5144/0256-4947.2007.284     Document Type: Review

References (13)

1. Gomberg-Maitland M, Frison L, Halperin JL Active-control clinical trials to establish equivalence or noninferiority: Methodological and statistical concepts linked to quality. Am Hearth J. 2003; 146:398-403.
2. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Annals of International Medicine. 2000;133(6):455-63.
3. McAlister FA, Sackett DL. Active-control equivalence trials and antihypertensive agents. Am J. Med. 2001;111:553-8.
4. Committee for Proprietary Medicinal Products (CPMP): Points to Consider on the Choice of Non-inferiority Magrin: London, 2004 February 26. CPMP/ EWP/2158/99 draft.
5. Committee for Proprietary Medicinal Products (CPMP); Points to Consider on Switching Between Superiority and Non-inferiority. London, 2000 July 27. CPMP/EWP/482/99.
6. Irving KH, Toshihiko M. Design issues in non-inferiority/equivalence trials. Drug Information Journal. 1999; 33:1205-18.
7. Streiner DL. Research methods in psychiatry, Can J Psychiatry. 2003;48:756-61.
8. Huson L. Statistical assessment of superiority, equivalence and non-inferiority in clinical trials. OR Focus. 2001;12(5):31-4.
9. Miller JA., Burke V. Relationship between sample size and the definition of equivalence in non-inferiority drug studies. J of Clinical Pharmacy & Therapeutics. 2002;27(5):329-33.
10. Ellenberg SS, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Annals of International Medicine. 2000;133(6):464-70.
11. Chung B, Zee Y. Planned equivalence or non-inferiority trials versus unplanned noninferiority claims: Are they equal? Journal of Clinical Oncology. 2006;24(7):1026-1028.
12. ICH Topic E9 Statistical Principles for Clinical Trials. Step 4, Consensus Guideline, 5 February 1998. The European Agency for The Evaluation of Medicinal Products Human Medicines Evaluation Unit. London, 1998 March 18. CPMP/ICH/363/96.
13. ICH Guideline E10: Choice of Control Groups in Clinical Trials (Step 2). http://www.hc-sc.gc.ca./hpfb-dgpsa/tpd-dpt/e10_e.html.